Plain-English translation of NCT06578156 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Read our COPD research guide โThis study doesn't follow the usual testing phases โ it may be an observational study or a different type of research.
This study is testing a device called nasal high flow, which delivers oxygen at a higher rate through a small tube in your nose. Researchers want to see if this treatment helps people with COPD walk farther and feel less short of breath compared to the standard low-flow oxygen most patients use today.
People with COPD often feel very tired and short of breath when they try to exercise or walk. Doctors want to know if delivering oxygen at a higher flow rate might help patients exercise more comfortably and improve their quality of life.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You will visit the research center once for about an hour. During your visit, you'll try two different oxygen delivery methods โ first one type for 30 minutes, then switch to the other type for 30 minutes. Between each treatment, you'll take a simple walking test to see how far you can walk and how short of breath you feel. The researchers will record your breathing, oxygen levels, and how you feel during each part.
AI-generated summary from trial data ยท Jun 30, 2026 ยท Not medical advice
United States
Sponsor
University of Miami
Collaborators
American Thoracic Society
Enrollment target
~45 participants
Started
December 2024
Primary completion
December 2027
Age range
18 Years โ 100 Years
Last updated on clinicaltrials.gov in June 2026.
Reach out to the team running this trial. Response times vary โ some teams are faster than others.
Central contact
Saramaria Afanador Castiblanco, M.D.
University of Miami
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first โ no email needed to get started.